The move comes as China rapidly expands its capabilities in the pharmaceutical sector, particularly in licensing and drug development
In 2025, over 1 million patients accessed Lilly treatments through LillyDirect
This multi-year CDMO agreement involves significant, ongoing manufacturing for a global pharmaceutical major
Bosentan 32 mg tablets for oral suspension are indicated for the treatment of Pulmonary Arterial Hypertension
The facility will bring 850 high-value jobs to the region, including engineers, scientists, operations personnel, and lab technicians
Aspect has acquired rights to Novo Nordisk’s stem cell-derived islet cell and hypoimmune cell engineering technologies
Penumbra projects fourth-quarter revenue growth of 21.4% to 22.0%, with full-year 2025 revenue expected to reach approximately $1.4 billion
The clearance marks a major step in Diabeloop’s ambition to become a central partner for insulin pump manufacturers and expand access to automated insulin delivery in the US market
New 35,000-square-foot facility in Winter Park will expand RLT manufacturing footprint to optimize delivery for patients across southeastern US
The new facility offers an expanded laboratory alongside meeting areas dedicated to development meetings, formulation workshops, and brainstorming sessions
Subscribe To Our Newsletter & Stay Updated
